Saudi Arabia

The Saudi Food and Drug Authority (SFDA) is the primary national regulatory body responsible for overseeing the registration, licensing, and post-market surveillance of health products in Saudi Arabia, including pharmaceuticals, medical devices, diagnostics, and digital health solutions. Established under Royal Decree M/42 (2003) and further empowered through subsequent legislation, the SFDA operates under a risk-based regulatory framework that aligns with international best practices. All health products must obtain SFDA marketing authorization before they can be commercially distributed or used within the Kingdom. The SFDA utilizes dedicated licensing pathways for different product categories, including the Drug Sector, Medical Devices Sector, and the National Center for Medical Devices (NCMD), each with its own submission portal and procedural requirements.

Applicants seeking SFDA registration must appoint a licensed Saudi local authorized representative (LAR) or a registered establishment in the Kingdom to act as the regulatory sponsor. Dossiers are generally submitted in the Common Technical Document (CTD) format for pharmaceuticals, while medical devices follow the IMDRF-aligned technical documentation framework, with conformity assessment evidence such as CE marking, FDA clearance, or equivalent recognized certifications often accepted to support expedited review. The SFDA has implemented a reliance pathway that allows applicants to leverage prior approvals from reference regulatory authorities including the EMA, US FDA, Health Canada, TGA, and other Gulf Cooperation Council (GCC) member state authorities via the Gulf Central Committee for Drug Registration (GCC-DR). Recent reforms under Vision 2030 have introduced digital submission platforms, accelerated review tracks for innovative and priority products, and enhanced transparency through published review timelines and guidance documents.

Public procurement of health products in Saudi Arabia is centrally coordinated through the Ministry of Health (MOH), which operates one of the largest government health systems in the region, managing an extensive network of public hospitals, primary health care centers, and specialty facilities. National-level procurement is conducted through the National Centre for Government Procurement (NCGP), formerly known as the National Unified Procurement Company (NUPCO), which serves as the primary aggregator for government health commodity purchasing and manages tenders on behalf of the MOH and other government health entities such as the National Guard Health Affairs, the Ministry of Defense Health Services, and university hospitals. Suppliers must be registered with the relevant government portal, including Etimad (the government financial platform) and Tenders.gov.sa, and products must hold valid SFDA registration to participate in public tenders. Framework agreements and long-term contracts are increasingly used to ensure supply continuity and cost efficiency, particularly for high-volume categories such as consumables, diagnostics, and pharmaceuticals.

The private sector represents a significant and growing procurement channel in Saudi Arabia, driven by a large network of private hospitals, clinics, pharmacies, and diagnostic laboratories concentrated in major urban centers such as Riyadh, Jeddah, and Dammam. Private procurement occurs through direct commercial relationships with licensed distributors and importers, with major private hospital groups and pharmacy chains conducting their own competitive tendering processes. Donor-funded or multilateral procurement channels such as UNICEF, the Global Fund, USAID, or Gavi play a limited role given Saudi Arabia's upper-middle to high-income country status, though the Kingdom does engage with global health initiatives in a donor capacity. To support Vision 2030 economic diversification objectives, the Saudi government has introduced local content and manufacturing preference policies, including incentives under the Local Content and Government Procurement Authority (LCGPA) framework, which encourages suppliers to increase in-Kingdom value addition, establish local manufacturing partnerships, and demonstrate measurable local content contributions as part of public tender evaluation criteria.